|
SEC24C expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.117580E-03 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.038800E-04 |
| Normal-vs-Stage2 |
1.733620E-01 |
| Normal-vs-Stage3 |
2.395000E-01 |
| Normal-vs-Stage4 |
9.983800E-03 |
| Stage1-vs-Stage2 |
5.397600E-01 |
| Stage1-vs-Stage3 |
3.761600E-02 |
| Stage1-vs-Stage4 |
9.350600E-01 |
| Stage2-vs-Stage3 |
5.588600E-01 |
| Stage2-vs-Stage4 |
5.512600E-01 |
| Stage3-vs-Stage4 |
1.195050E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.664800E-03 |
| Normal-vs-AfricanAmerican |
7.335400E-03 |
| Normal-vs-Asian |
7.608800E-04 |
| Caucasian-vs-AfricanAmerican |
4.946800E-01 |
| Caucasian-vs-Asian |
1.177560E-01 |
| AfricanAmerican-vs-Asian |
1.348160E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.908430E-01 |
| Normal-vs-Female |
7.40070005278426E-09 |
| Male-vs-Female |
2.29940000373574E-08 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.155400E-01 |
| Normal-vs-Age(41-60Yrs) |
2.124800E-03 |
| Normal-vs-Age(61-80Yrs) |
3.882700E-03 |
| Normal-vs-Age(81-100Yrs) |
2.734600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.071000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.743200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.244400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.233800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.110400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.840800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.43479999997953E-06 |
| Normal-vs-Grade 2 |
6.166400E-04 |
| Normal-vs-Grade 3 |
5.496200E-02 |
| Normal-vs-Grade 4 |
5.838700E-03 |
| Grade 1-vs-Grade 2 |
3.162100E-02 |
| Grade 1-vs-Grade 3 |
8.364200E-03 |
| Grade 1-vs-Grade 4 |
4.574200E-02 |
| Grade 2-vs-Grade 3 |
1.135380E-01 |
| Grade 2-vs-Grade 4 |
8.378200E-01 |
| Grade 3-vs-Grade 4 |
1.845610E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.25099999995315E-06 |
| Normal-vs-ccB subtype |
7.952400E-01 |
| ccA subtype-vs-ccB subtype |
1.53197999999133E-05 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.464100E-03 |
| Normal-vs-N1 |
2.44459999999558E-05 |
| N0-vs-N1 |
5.603900E-02 |
|
|
